Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  January 17, 2013
In This Edition
News Roundup: ERT Forms Fully-Owned Subsidiary in Japan
Articles: China Takes Center Stage
Blog Posts: Selling Specialty Drugs in China
Marketplace: Marketplace

News Roundup
bullet ERT’s Registration Broadens Local Services in Japan
bullet Asian CROs Select Oracle’s InForm Solution
bullet WuXi PharmaTech, PRA Form Joint Chinese Venture
bullet First Taiwanese Hospital Receives AAHRP Accreditation

Articles
bullet Outsourcing: China Takes Center Stage
bullet Asia-Pac Physicians’ Outlook on Participating in Trials

Blogs Posts
bullet Selling Specialty Drugs in China
bullet Is Pharma Rightsized?

Events
bullet Global Clinical Sourcing and Supply Summit
bullet ClinTech 2013

Marketplace

Sponsored
PRA
The Unit on Demand Clinical Trial Model
A leading CRO delivering all phases of biopharmaceutical drug development.
Recent trends have seen first-into-man trials moving to patient populations earlier in drug development process. One issue still hampers this model: how to recruit patients? Traditional recruitment methods have consistently failed to get a sufficient number of patients into studies conducted in phase I units. One recruitment model which has proven successful is to reverse the paradigm. Rather than asking the patient to come to the unit, take the unit to the patient.
Download Whitepaper

Sponsored
PRA International
PRA and WuXi PharmaTech sign joint venture agreement to offer biopharmaceutical companies complete range of Phase I-IV clinical trial services in China. Read More

Sponsored
PRA Podcast-1
Early Phase Patient Studies: Can you describe conventional vs. non-conventional recruitment models? www.appliedclinicaltrialsonline.com/sponsoredpodcasts


Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com